CompletedNot Applicable

Laser Acupuncture for Pulmonary Function Test and Quality of Life in COPD Patients

Indonesia40 participantsStarted 2025-08-01

Plain-language summary

This clinical trial aims to evaluate the effectiveness and safety of laser acupuncture as an adjunct therapy in patients with chronic obstructive pulmonary disease (COPD). The main research questions are: * Does laser acupuncture, when combined with standard pharmacological treatment, improve lung function (measured by FEV1% and FEV1/FVC ratio) more than sham laser acupuncture after 4 weeks of therapy? * Does this combination also lead to better quality of life, as assessed by the COPD Assessment Test (CAT) and the St. George's Respiratory Questionnaire (SGRQ), compared to the control group, after 4 and 8 weeks? * Is there a correlation between lung function (FEV1%) and quality of life scores (CAT and SGRQ)? * Are there any significant adverse effects caused by laser acupuncture compared to sham treatment? Participants will: * Undergo spirometry and complete CAT and SGRQ questionnaires. * Receive either laser acupuncture or sham laser acupuncture sessions. * Return for follow-up assessments at 4 and 8 weeks.

Who can participate

Age range

20 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with stable chronic obstructive pulmonary disease (COPD) based on the Global Initiative for COPD (GOLD). * No acute exacerbation in the last 4 weeks. * Male or female participants aged 20 to 80 years. * Willing to participate in the study until completion and has signed informed consent. Exclusion Criteria: * History of lung surgery as treatment for COPD. * Psychiatric or cognitive disorders. * Underwent acupuncture within the last 2 weeks. * Pregnant or breastfeeding. * Presence of wounds or skin disorders at the laser acupuncture site. * History of uncontrolled epilepsy. * Fever \> 38.0°C.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Forced Expiratory Volume in One Second (FEV1%)

Timeframe: Baseline and 4 weeks after intervention

FEV1/FVC Ratio

Timeframe: Baseline and 4 weeks after intervention

COPD Assessment Test (CAT) Score

Timeframe: Baseline, 4 weeks, and 8 weeks after intervention

St. George's Respiratory Questionnaire (SGRQ) Score

Timeframe: Baseline, 4 weeks, and 8 weeks after intervention

Trial details

NCT IDNCT07030452

SponsorIndonesia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-10

View on ClinicalTrials.gov More Chronic Pulmonary Obstruction trials

Plain-language summary

Who can participate

Age range

20 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Forced Expiratory Volume in One Second (FEV1%)

Timeframe: Baseline and 4 weeks after intervention

FEV1/FVC Ratio

Timeframe: Baseline and 4 weeks after intervention

COPD Assessment Test (CAT) Score

Timeframe: Baseline, 4 weeks, and 8 weeks after intervention

St. George's Respiratory Questionnaire (SGRQ) Score

Timeframe: Baseline, 4 weeks, and 8 weeks after intervention